Reginald Tucker-Seeley, M.A., Sc.M., Sc.D.

Vice President, Health Equity
ZERO - The End of Prostate Cancer

Fellowship Profile

Fellowship Year: 2017-2018
Fellowship Placement: Sen Feinstein (D-CA)
Sponsoring Institution: University of Southern California
Disciplines / Professions: Epidemiology, Public Health

Biography

Dr. Tucker-Seeley is currently the Vice-President of Health Equity at ZERO-The End of Prostate Cancer. In this role, he leads the development and implementation of ZERO’s health equity strategy to reduce racial/ethnic and place-based disparities in prostate cancer. Dr. Tucker-Seeley completed master and doctoral degrees in public health at the Harvard T.H. Chan School of Public Health (HSPH) and a postdoctoral fellowship in cancer prevention and control at HSPH and the Dana-Farber Cancer Institute (DFCI). His research has focused on social determinants of health across the life course, such as the association between the neighborhood environment and health behavior; and on individual-level socioeconomic determinants of multi-morbidity, mortality, self-rated physical, mental, and oral health. His research has also investigated the association of financial hardship with health across the chronic disease continuum from prevention to end-of-life care.

Dr. Tucker-Seeley has a longstanding interest in the impact of health policy and social policy on racial/ethnic minorities and across socioeconomic groups. He has experience working on local and state level health disparities policy, and he has developed and taught courses focused on measuring and reporting health disparities. In 2017-2018, Dr. Tucker-Seeley was a Robert Wood Johnson Health Policy Fellow with a placement in the United States Senate. Prior to joining ZERO, he was the inaugural holder of the Edward L. Schneider chair in gerontology and Assistant Professor in the Leonard Davis School of Gerontology at the University of Southern California (USC). Prior to joining USC, he was an Assistant Professor of Social and Behavioral Sciences at DFCI and HSPH.